INGRAM DOUGLAS S
SEC CIK 1190644 · EDGAR
BoughtSold
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
| 12 | INGRAM DOUGLAS S | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | INGRAM DOUGLAS S | Dir | A - Grant | $0.00 | +7,819 | 46.2K | +20% | $0 | |
| M | 2025-12-09 | 2025-12-07 | SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | CEO, Dir | A - Grant | $0.00 | +539.1K | 659.8K | +446% | $0 |
| 2025-02-07 | 2025-02-06 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | INGRAM DOUGLAS S | Dir | A - Grant | $20.09 | +38.4K | 38.4K | New | +$771.4K | |
| M | 2023-11-06 | 2023-11-03 | SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | Pres, CEO, Dir | P - Purchase | $79.36 | +25.2K | 390.1K | +7% | +$2.00M |
| 2021-11-17 | 2021-11-17 | SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | Pres, CEO, Dir | P - Purchase | $79.94 | +25.0K | 365.1K | +7% | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations